Horizon Therapeutics (BSP:H1ZN34) Total Debt per Share : R$5.46 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Horizon Therapeutics Total Debt per Share?

R$5.46 (As of Jun. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Horizon Therapeutics's Total Debt Per Share for the quarter that ended in Jun. 2023 was R$5.46.

Horizon Therapeutics Total Debt per Share Historical Data

The historical data trend for Horizon Therapeutics's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Horizon Therapeutics Total Debt per Share Chart

Horizon Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Debt per Share

Get a 7-Day Free Trial

4.36

2.95

2.33

6.43

5.95

Horizon Therapeutics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Debt per Share	Get a 7-Day Free Trial															5.63	5.88	5.95	5.87	5.46

Horizon Therapeutics Total Debt per Share Calculation

Horizon Therapeutics's Total Debt Per Share for the fiscal year that ended in Dec. 2022 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(13,443	+	84)	/	2,272
	=	5.95

Horizon Therapeutics's Total Debt Per Share for the quarter that ended in Jun. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(12,335	+	78)	/	2,272
	=	5.46

Horizon Therapeutics Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Horizon Therapeutics's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Horizon Therapeutics (BSP:H1ZN34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Horizon Therapeutics PLC (BSP:H1ZN34) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

70 St. Stephen’s Green, Dublin, IRL, D02 E2X4

Website

https://www.horizontherapeutics.com

Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

Horizon Therapeutics (BSP:H1ZN34) Headlines

No Headlines